Prof Deborah Gill to Present at The European Society of Gene and Cell Therapy Conference

Wednesday, September 16th 2015

Print this page

ESGCT_Logo.jpgThe annual European Society of Gene and Cell Therapy Conference takes place in Helsinki this weeken (09-17 to 09-20).

The Consortium will be represented by Prof Deborah Gill who will present the results of out MD Clinical Trial.

This marks the first time the results of the trial have been presented to a gene therapy specific audience since the publication of the results in July.

You can read the abstract below and we should have Deborah's full presentation soon.

'A Phase 2b clinical trial of non-viral gene therapy in Cystic Fibrosis patients: randomized, double-blind, placebo-controlled repeated aerosol delivery to the lungs.'

 

Prof Gill discussing gene therapy in 2008.


 

Proposed 3D model of the CFTR protein.

 

DNA fragments being cut from an agarose gel exposed to UV.